Chris Velasquez

An mRNA cancer vaccine developed at the University of Florida has attracted widespread news coverage.

The project builds on the team’s recent development of a PROTAC that showed potential as a small-molecule-based therapy.

Construction is well underway on the unit and it is expected to launch this fall.

The team evaluated the relationship between several reproductive factors and a novel measurement of breast image intensity.

The honor is among the most distinctive in academia and recognizes extraordinary impact and achievement across disciplines.  

Experts from across the nation joined with UF faculty and students to present and exchange ideas on end-of-life care.

The goal is to identify modifiable factors that contribute to colorectal cancer risk and affect health outcomes of patients with colorectal cancer.

Andrew Maxim plans to continue his cancer research in virtual environments and focus on HPV vaccine efforts.  

Carolyn M. Tucker, Ph.D., was recognized for her research, leadership and commitment to her work, her community and to her field.

Recipients are recognized for efforts that benefit ASCO, the speciality of oncology and the patients they serve.